Fundraising Fox
Amy Schulman
InvestorFounderManaging Partner at Polaris Partners · Founder at Lyndra
Mount Pleasant, South Carolina
Writes $300K – $2M checks · typically $500K
FoundedLyndra
Find your path to Amy
Sign up to see every warm intro you have to Amy
- Paths you didn't know you had: your email and LinkedIn already hold routes to Amy. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Amy Schulman is a managing partner at Polaris Partners focused on healthcare companies and early stage biotech startups. She joined the firm in 2014 and co-founded the Polaris Innovation Fund in 2017, which she continues to manage. Before Polaris she held roles at Pfizer including general counsel and president of Pfizer Nutrition and Pfizer Consumer Healthcare, was a partner at DLA Piper, and began her career at Cleary Gottlieb Steen & Hamilton; she is also a Senior Lecturer at Harvard Business School and holds degrees from Wesleyan University and Yale Law School.
Contact· self-published, not guessed
Invests in
BiotechHealthtech
Founder at Lyndra
Intro paths
In turn, Amy can intro founders to Lyndra's investors below.
Lyndra's investors · 6
Co-founders at Lyndra
Deals · 11
ByHeartBoard seat
via Polaris Partners · filed May 2026 · $95.5M raise
SequelaeBoard seat
via Polaris Partners · filed Nov 2025 · $1.5M raise
QuralisBoard seat
via Polaris Partners · filed Sep 2025 · $24.9M raise
NoetikBoard seat
via Polaris Partners · filed Aug 2024 · $40M raise
LyndraBoard seat
via Polaris Partners · filed Dec 2023 · $206.1M raise
Cardurion Pharmaceuticals, Inc.Board seat
via Polaris Partners · filed Dec 2022 · $17.5M raise
Amagma, Inc.Board seat
via Polaris Partners · filed Dec 2022 · $10M raise
FractylBoard seat
via Polaris Partners · filed Jan 2022 · $20.1M raise
Glympse BioBoard seat
via Polaris Partners · filed Dec 2021 · $18M raise
Cyclerion TherapeuticsBoard seat
via Polaris Partners · filed Aug 2020 · $24.3M raise
X4 PharmaBoard seat
via Polaris Partners · filed May 2017 · $50.5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Alnylam PharmaceuticalsElevance HealthKallyopeLarkspur
Investor
ArsanisBIND TherapeuticsCardurion PharmaceuticalsEngine BioLarkspur BiosciencesQuentis TherapeuticsSQZ BiotechTessa TherapeuticsThirty MadisonVico TherapeuticsVolastra
Sources: the firm's website · SEC Form D filings · curated public sources.
Colleagues at Polaris Partners
Network12
Investors connected to Amy in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Amy Schulman?
- Amy Schulman is a managing partner at Polaris Partners focused on healthcare companies and early stage biotech startups. She joined the firm in 2014 and co-founded the Polaris Innovation Fund in 2017, which she continues to manage. Before Polaris she held roles at Pfizer including general counsel and president of Pfizer Nutrition and Pfizer Consumer Healthcare, was a partner at DLA Piper, and began her career at Cleary Gottlieb Steen & Hamilton; she is also a Senior Lecturer at Harvard Business School and holds degrees from Wesleyan University and Yale Law School.
- Where does Amy Schulman work?
- Amy Schulman is Founder of Lyndra and Managing Partner at Polaris Partners.
- What does Amy Schulman invest in?
- Amy Schulman invests in Biotech, Healthtech.
- What check size does Amy Schulman write?
- Amy Schulman typically writes checks of $300K – $2M.
- What companies did Amy Schulman found?
- Amy Schulman founded Lyndra.
- What boards does Amy Schulman sit on?
- Amy Schulman holds tracked board seats at Alnylam Pharmaceuticals, Amagma, Inc., ByHeart, Cardurion Pharmaceuticals, Inc., Cyclerion Therapeutics, Elevance Health, Fractyl, Glympse Bio, Kallyope, Larkspur.
- What companies has Amy Schulman invested in?
- Investments tracked here include Arsanis, BIND Therapeutics, ByHeart, Cardurion Pharmaceuticals, Engine Bio, Glympse Bio, Larkspur Biosciences, Noetik, Quentis Therapeutics, Quralis, SQZ Biotech, Tessa Therapeutics, and 3 more.
Founder mafias
Polaris Partners mafia7
Also came through, then founded or led a company.
Glympse Bio mafia6
Also came through, then founded or led a company.
Quralis mafia5
Also came through, then founded or led a company.
ByHeart mafia3
Also came through, then founded or led a company.
Noetik mafia3
Also came through, then founded or led a company.
About this profile. Compiled from public sources — Polaris Partners's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights